Abstract.
Background: The prognosis of medulloblastoma in children under 3 years of age is poor. Methods: A retrospective analysis was performed to evaluate children under 3 years of age with medulloblastoma. Overall survival (OS) and progression-free survival (PFS) were assessed in children with and without metastasis. Results: A total of 534 children were diagnosed with medulloblastoma during the study period, 49 (9.1%) of whom were under 3 years of age and were evaluated. Their ages ranged from 5 to 35 months with a mean of 18.5 months. In 39 (79.6%) of these patients the tumors were staged as T3M0 or under, while 10 (20.4%) had metastasis at diagnosis. The OS was 38% and PFS 37% in the whole series, while PFS was 32% in those with metastasis and 40% in those without (P=0.78). For those who received radiotherapy the PFS was 62%, and in those not treated with radiotherapy PFS was nil (P=0.0001). When the children were divided into those who received surgical treatment plus chemotherapy and those who received surgery plus radiotherapy plus chemotherapy, the PFS was nil and 66%, respectively (P=0.00001). Conclusion: Because of the high morbidity of radiotherapy in children under 3 years old, surgery continues to be the basis of improved prognosis, followed by chemotherapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Rivera-Luna, R., López, E., Rivera-Marquez, H. et al. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP). Child's Nerv Syst 18, 38–42 (2002). https://doi.org/10.1007/s00381-001-0527-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-001-0527-2